Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palatability of oral iron formulations in children
ChiCTR2100052443Phase 4Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Sep 2021
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of iron dextran and Iron protein succinylate in iron deficiency anemia (IDA) (2 arms), sponsored by Beijing Children's Hospital. Primary endpoints: Drug palatability, Facial expression analysis and 2 more. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
iron dextranIron protein succinylate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ChiCTR2100052443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052443.